Bayer AG
BAYRY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $27,755,644 | $25,174,218 | $21,861,132 | $18,519,073 |
| - Cash | $6,928,975 | $4,557,000 | $4,015,000 | $6,191,000 |
| + Debt | $46,574,650 | $45,107,534 | $39,385,000 | $40,697,000 |
| Enterprise Value | $67,401,319 | $65,724,752 | $57,231,132 | $53,025,073 |
| Revenue | $11,288,172 | $10,739,000 | $13,738,000 | $11,729,000 |
| % Growth | 5.1% | -21.8% | 17.1% | – |
| Gross Profit | $6,255,237 | $6,375,000 | $8,113,000 | $6,006,000 |
| % Margin | 55.4% | 59.4% | 59.1% | 51.2% |
| EBITDA | $606,000 | $236,000 | $3,588,000 | $1,671,000 |
| % Margin | 5.4% | 2.2% | 26.1% | 14.2% |
| Net Income | -$1,125,312 | -$199,000 | $1,299,000 | -$335,000 |
| % Margin | -10% | -1.9% | 9.5% | -2.9% |
| EPS Diluted | -0.29 | -0.05 | 0.33 | -0.085 |
| % Growth | -480% | -115.2% | 488.2% | – |
| Operating Cash Flow | $1,591,772 | $1,058,000 | -$1,015,000 | $4,997,000 |
| Capital Expenditures | -$975,677 | -$465,000 | -$388,000 | -$1,099,000 |
| Free Cash Flow | $616,094 | $593,000 | -$1,403,000 | $3,898,000 |